Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism (COVET)

Trial Profile

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism (COVET)

Phase of Trial: Phase IV

Latest Information Update: 16 Nov 2018

At a glance

  • Drugs Apixaban (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COVET
  • Most Recent Events

    • 01 Nov 2018 Planned number of patients changed from 3165 to 3000.
    • 01 Nov 2018 Status changed from not yet recruiting to recruiting.
    • 28 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top